Hims & Hers Health, Inc. (NYSE:HIMS) Shares Acquired by Principal Financial Group Inc.

Principal Financial Group Inc. increased its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS) by 102.0% during the third quarter, HoldingsChannel.com reports. The fund owned 290,414 shares of the company’s stock after buying an additional 146,621 shares during the period. Principal Financial Group Inc.’s holdings in Hims & Hers Health were worth $5,349,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. Quest Partners LLC boosted its holdings in shares of Hims & Hers Health by 5,944.1% during the 2nd quarter. Quest Partners LLC now owns 3,566 shares of the company’s stock worth $72,000 after purchasing an additional 3,507 shares during the last quarter. CWM LLC boosted its stake in Hims & Hers Health by 21.4% during the third quarter. CWM LLC now owns 5,982 shares of the company’s stock worth $110,000 after buying an additional 1,054 shares during the last quarter. Van ECK Associates Corp purchased a new stake in Hims & Hers Health in the 2nd quarter valued at $111,000. Quarry LP grew its stake in shares of Hims & Hers Health by 91.0% in the 3rd quarter. Quarry LP now owns 6,113 shares of the company’s stock valued at $113,000 after buying an additional 2,913 shares during the period. Finally, Amalgamated Bank raised its position in shares of Hims & Hers Health by 55.9% during the 2nd quarter. Amalgamated Bank now owns 6,566 shares of the company’s stock valued at $133,000 after buying an additional 2,354 shares during the period. Hedge funds and other institutional investors own 63.52% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on HIMS. Deutsche Bank Aktiengesellschaft raised their target price on Hims & Hers Health from $23.00 to $27.00 and gave the stock a “hold” rating in a research note on Wednesday, November 6th. Bank of America lowered shares of Hims & Hers Health from a “buy” rating to an “underperform” rating and reduced their price objective for the company from $32.00 to $18.00 in a report on Thursday, November 14th. TD Cowen reaffirmed a “buy” rating and set a $28.00 target price on shares of Hims & Hers Health in a research note on Wednesday, November 20th. Piper Sandler reissued a “neutral” rating and issued a $21.00 price target (up from $18.00) on shares of Hims & Hers Health in a research note on Tuesday, November 5th. Finally, Morgan Stanley assumed coverage on shares of Hims & Hers Health in a research report on Tuesday, December 17th. They set an “overweight” rating and a $42.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $22.80.

Insider Activity at Hims & Hers Health

In related news, COO Melissa Baird sold 58,750 shares of Hims & Hers Health stock in a transaction on Monday, October 7th. The shares were sold at an average price of $19.57, for a total transaction of $1,149,737.50. Following the sale, the chief operating officer now directly owns 630,166 shares in the company, valued at $12,332,348.62. This trade represents a 8.53 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Michael Chi sold 2,054 shares of the firm’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $33.56, for a total value of $68,932.24. Following the transaction, the insider now directly owns 184,947 shares in the company, valued at approximately $6,206,821.32. The trade was a 1.10 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,133,132 shares of company stock valued at $28,059,037 over the last quarter. 17.71% of the stock is owned by insiders.

Hims & Hers Health Stock Performance

Shares of HIMS opened at $24.18 on Thursday. Hims & Hers Health, Inc. has a 1 year low of $8.09 and a 1 year high of $35.02. The stock has a market capitalization of $5.28 billion, a PE ratio of 54.96 and a beta of 1.25. The stock has a 50-day simple moving average of $26.43 and a 200-day simple moving average of $21.48.

Hims & Hers Health (NYSE:HIMS) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.06 by $0.26. Hims & Hers Health had a net margin of 8.19% and a return on equity of 10.97%. The company had revenue of $401.56 million during the quarter, compared to the consensus estimate of $382.20 million. During the same quarter in the previous year, the firm earned ($0.04) earnings per share. The firm’s quarterly revenue was up 77.1% on a year-over-year basis. Analysts predict that Hims & Hers Health, Inc. will post 0.29 EPS for the current year.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.